Meningitis clinical trials

Explore recruiting meningitis clinical trials.

Recruiting meningitis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Meningitis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

PHASE III, OPEN-LABEL, RANDOMIZED, CONTROLLED, NON-INFERIORITY CLINICAL-TRIAL TO ASSESS THE EFFICACY AND SAFETY OF SHORT OUTPATIENT AMOXICILLIN REGIMENS IN CHILDREN WITH ACUTE STREPTOCOCCAL PHARYNGOTONSILLITIS (STOP – TRIAL)

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Aciclovir for HSV-2 MENingitis: A double-blinded randomised controlled trial (AMEN)

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

A Phase II, Randomized, Partially Blinded Study to Assess the Safety, Tolerability and Immunogenicity of Meningococcal Combined ABCWY Vaccine when Administered to Healthy Infants

Poland, Spain, Germany

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A Phase 2b, Randomized, Observer-Blinded Trial to Describe the Safety, Tolerability, and Immunogenicity of MenABCWY Administered on Different Dosing Schedules in Healthy Participants ≥11 to <15 Years of Age

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Primary and booster meningococcal vaccination in Dutch elderly: study to investigate the immune response and determine functional antibodies after the tetravalent MenACWY-TT conjugate vaccine in the elderly population

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

BRECHE : Efficacy of sphenopalatine block compared to blood patch in the management of post-dural puncture syndrome.

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Meningitis trials by city

Meningitis in Toronto Meningitis in Vancouver Meningitis in Montreal Meningitis in Calgary Meningitis in Edmonton Meningitis in Ottawa Meningitis in Winnipeg Meningitis in Quebec City Meningitis in Hamilton Meningitis in Kitchener Meningitis in London Meningitis in Halifax Meningitis in New York Meningitis in Los Angeles Meningitis in Chicago Meningitis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease